New device trial offers hope for advanced breast cancer patients out of options
NCT ID NCT07227831
Summary
This study is testing a device called TheraBionic P1 to see if it can help control advanced breast cancer and help patients live longer. It is for women whose cancer has spread and has stopped responding to standard hormone therapies and chemotherapy. The device is held in the mouth and delivers a specific type of energy, aiming to slow or stop the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.